This is an observational study to better understand the risk factors and progression of CADASIL, a leading cause of vascular cognitive impairment and dementia (VCID). 575 participants will be enrolled and can expect to be on study for up to 5 years.
CADASIL
This is an observational study to better understand the risk factors and progression of CADASIL, a leading cause of vascular cognitive impairment and dementia (VCID). 575 participants will be enrolled and can expect to be on study for up to 5 years.
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
-
University of California, Los Angeles, California, United States, 90095
University of California, San Francisco, California, United States, 94143
University of Colorado, Denver, Colorado, United States, 80204
Georgia State University Research Foundation, Atlanta, Georgia, United States, 30303
Loyola University, Chicago, Illinois, United States, 60660
Columbia University, New York City, New York, United States, 10027
Oregon Health & Science University, Portland, Oregon, United States, 97239
Brown University, Providence, Rhode Island, United States, 02912
University of Texas Health Science Center, Houston, Texas, United States, 77030
University of Texas, San Antonio, Texas, United States, 78249
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
Yes
University of Wisconsin, Madison,
Jane S Paulsen, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison
Michael D Geschwind, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
2026-01